Stocks and Investing Stocks and Investing
Fri, November 6, 2020
Thu, November 5, 2020

Jonathan Chang Maintained (ADAP) at Hold with Decreased Target to $6 on, Nov 5th, 2020


Published on 2024-10-27 14:39:13 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Decreased Target from $10 to $6 on, Nov 5th, 2020.

Jonathan, nor any peers, have made any analyst calls on ADAP in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources